维普中文期刊产品整合服务
172篇 您的检索式:作者名="Chrysant"
    题名 作者 年代 出处 被引量
1Clinical Implications of Cardiovascular Preventing Pleiotropic Effects of Dipeptidyl Peptidase-4 Inhibitors显示文摘Steven G. Chrysant George S. Chrysant 2012The American Journal of Cardiology2012,,11:2
2Clinical implications of cardiovascular preventing pleiotropic effects of dipeptidyl peptidase-4 inhibitors 显示文摘Chrysant SG Chrysant GS 2012American Journal of Cardiology2012,109,:1
3The pathophysiologie role of the brain Renin- Angiotensin system in stroke protection: elinicalimplications 显示文摘Chrysant SG 2007J Clin Hypertens(Greenwich)2007,9,11:1
4Clinical implications of cardiovascular preventing pleiotropic effects of dipeptidyl peptidase-4 inhibitors显示文摘Chrysant SG Chrysant GS 0,,:1
5Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases显示文摘Chrysant SG 2010Am J Cardiol2010,105,6:1
6long-term safety,tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension:a 6-month interim analysis显示文摘Chrysant SG Murray AV Hopppe UC 2008Curr Med Res Opin2008,24,:1
7Renin inhibition aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide显示文摘Villamil A Chrysant SG Calhoun D 2007J Hypertens2007,25,:1
8Telmisartan/hydrochlorothiazide in comparison with losartan/ hydrochlorothiazide ill managing patients with mild-to-moderate hypertension显示文摘NEUTEL JM LITTLEJOHN TW CHRYSANT SG 2005Hypertens Res2005,28,7:1
9The treatment of cardiovascular disease continuum:focus on prevention and RAS blockade显示文摘Chrysant S G Chrysant G S Chrysant C 2010Curr Clin Pharmacol2010,5,2:1
10Coronary artery stent patency assessed with in-stent contrast enhancement measured at multi-detector row CTangiography: initial experience显示文摘Hong C Chrysant GS Woodard PK 2004Radiology2004,233,1:1
11Comparative efficacy of olmesartan,losartan,Valsartan,and Lrbesartan in the control of essentlal hypertenslon显示文摘Oparll S williams D chrysant SG 2001J Clin Hypertens(Greenwich)2001,3,29:1
12Chrysant, Clinical implications of cardiovascular preventing pleiotropic effects of dipeptidyl peptidase-4 inhibitors 显示文摘Chrysant S G Chrysant G S 2012Am JCardiol2012,109,11:1
13New insights into the true nature of the obesity paradox and the lower cardiovascular risk显示文摘Chrysant SG Chrysant GS 2013J Am Soc Hypertens2013,7,1:1
14The importance of early antihypertensive efficacy:the role of angiotensin II receptor blocker therapy显示文摘Basile JN Chrysant S 2006J Hum Hypertens2006,20,3:1
15Antihypertensive efficacy and safety of olmesartan medoxomil compered with amlodipine for mild-to-moderate hypertension显示文摘Chrysant S G Marbury T C Robinson T D 2003J Hum Hyperten2003,17,6:1
16New insights into the true nature of the obesity paradox and the lower cardiovascular risk 显示文摘Chrysant SG Chrysant GS 2013Journal of the American Society of Hypertension2013,7,1:1
17Effectiveness of the fixed-dose combi- nation of olmesartan amlodipine hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD显示文摘CHRYSANT S G 2013Expert Rev Car- diovasc Ther2013,11,9:1
18Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide 显示文摘Villamil A Chrysant SG Calhoun D 2007J Hypertens2007,25,1:1
19Renin inhibiton with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide 显示文摘Villamil A Chrysant SG Calhoun D 2007J Hypertens2007,25,:1
20Future of the polypill use for the pre vention of cardiovascular disease and strokes显示文摘Chrysant SG Chrysant GS 2014Am J Cardiol2014,114,4:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费